This spring, the field's brightest academic scientists joined leaders in industry to share promising research and encourage collaboration on the road to clinical breakthroughs.
Damon Runyon funds the best early-career scientists in cancer research, who have great potential to achieve breakthroughs in how we diagnose, treat and prevent cancer.